Targovax ASA (GB:0RIS) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Circio Holding ASA is making strides in biotechnology with its innovative circular RNA (circRNA) vector expression platform, offering enhanced protein expression for nucleic acid medicines. The company’s pan-RAS cancer vaccine, TG01, is also progressing through clinical trials in the USA and Norway, backed by significant research funding. These developments position Circio as a promising player in the field of advanced therapeutics.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Nike Q2 Earnings Preview: Analysts Expect a Decline in Earnings and Sales
- Salesforce Hits 1,000 Agentforce Deals, Launches Agentforce 2.0
- Starbucks’ Union Threatens Strike at the 11th Hour
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
